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Introduction. Adding stem cells to biodegradable scaﬀolds to enhance bone regeneration is a valuable option. Diﬀerent kinds of stem
cells with osteoblastic activity were tested, such as bone marrow stromal stem cells (BMSSCs). Aim. To assess a correct protocol for
osteogenic stem cell diﬀerentiation, so BMSSCs were seeded on a bone porcine block (BPB).Materials and Methods. Bone marrow
from six minipigs was extracted from tibiae and humeri and treated to isolate BMSSCs. After seeding on BPB, critical-size defects
were created on each mandible of the minipigs and implanted with BPB and BPB/BMSSCs. After three months,
histomorphometric analysis was performed. Results. Histomorphometric analysis provided percentages of the three groups.
Tissues present in control defects were 23 ± 2% lamellar bone, 28 ± 1% woven bone, and 56 ± 4% marrow spaces; in BPB defects
were 20 ± 5% BPB, 32 ± 2% lamellar bone, 24 ± 1% woven bone, and 28 ± 2% marrow spaces; in BPB/BMSSCs defects were 17 ± 4%
BPB/BMSSCs, 42 ± 2% lamellar bone, 12 ± 1% woven bone, and 22 ± 3% marrow spaces. Conclusion. BPB used as a scaﬀold to
induce bone regeneration may beneﬁt from the addition of BDPSCs in the tissue-engineered constructs.
1. Introduction
1.1. Bone Regeneration with Stem Cells. A common problem
facing the dental community is the rehabilitation of oral func-
tions in patients with edentulous atrophic alveolar process.
Improvement of successful methods to induce bone regenera-
tion is a continuous challenge in dentistry [1]. In recent years,
the use of biomaterials to enhance bone regeneration has
greatly developed because of their capacity to mimic the
natural environment of the extracellular matrix [2]. To
increase the eﬀectiveness of this methodology, the use of bio-
materials, or scaﬀolds, in association with stem cells with
osteoblast-like activity has been introduced [3, 4]. In 1968,
Friedenstein et al. ﬁrst published works demonstrating the
osteogenic property of bone marrow transplants in diﬀerent
tissues and the possibility of cultivating, cloning, and retrans-
planting in vivo [5]. A number of stem cell studies have
followed [6, 7]. Adultmesenchymal stem cells can be obtained
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frommany sources. In particular, they can successfully be dif-
ferentiated in osteoblast-like cells originating from diﬀerent
dental tissues [8–11].
1.2. BMSSC.Among the stem cells with the desired osteoblas-
tic activity, BMSSCs have proved eﬀective in inducing new
bone formation in critical-size defects of animal models
[12–14]. Indeed, the ability of those cells to enhance bone
formation can even be found in scaﬀold-type constructions,
tridimensional shapes, and the culturalization of cells. In
recent years, several matrices have been used, from nonre-
sorbable biomaterials, such as hydroxyapatite, in diﬀerent
relationships with BMSSCs, including layers encapsulated
in hydrogel [15] or calcined bovine bone [16], to resorbable
ones such as beta-tri-calcium phosphate (β-TCP) or calcium
phosphate (CP) [17]. When comparing matrices, one study
found a better response in vivo and in vitro from calcium
phosphate rather than hydroxyapatite on increased trabecula
formation, cell density, and decreased ﬁbrosis [18]. Regard-
less of the results, there is still no universally accepted scaﬀold
and each one has to be tested individually.
On those scaﬀolds, BMSSCs are cultured in situ improv-
ing bone healing and matrix reabsorption with an osteogenic
eﬀect. In a recent experiment, BMSSCs with an enriched
chitosan scaﬀold produced bone, more than CP alone in rat
muscle [19]. BMSSCs are the nonhematopoietic elements of
the bone marrow (BM). This cluster of cells comprises less
than 0.01% of the overall cell population residing in the BM
[20]. The nonhomogeneous nature of BMSSCs is clearly
evident when examining individual colonies. Diﬀerent cell
morphologies include spindle cells, ﬁbroblast-like cells, or
colonies of large and ﬂat-shaped cells. Furthermore, if such
cultures are allowed to develop for up to 20 days, phenotypic
heterogeneity is also noted. Some colonies are highly positive
for alkaline phosphatase (ALP), while others are negative,
and a third type is positive in the central region and negative
in the periphery [21]. Some colonies form nodules of miner-
alized matrix which can be identiﬁed by alizarin red or von
Kossa staining for calcium. Yet others accumulate fat, identi-
ﬁed by oil red O staining [22], while some colonies form
cartilage as identiﬁed by alcian blue staining [23]. In a recent
study [24] on mice mesenchymal stem cells derived from
dental pulp and periosteum, a diﬀerence in bone regenera-
tion was found, conﬁrming the hypothesis of enhancing
regeneration with mesenchymal stem cells. It was measured
as a percentage of bone volume on the total defect area, when
seeded with scaﬀold block deproteinized porcine bone
(BDPB) alone and with dental pulp and periosteal stem cells.
Qualitative observations on bone histomorphometry classify
the nature of bone elements as either lamellar or woven. The
presence of residual biomaterial and inﬂammatory mediators
within the defects was also observed. A similar model has
been adopted in this study to evaluate diﬀerent degrees of
bone regeneration using bone porcine block with bone
marrow stromal stem cells (BPB/BMSSCs).
The aim of this study is to assess a correct protocol for
osteogenic stem cell diﬀerentiation of an osteoblastic pheno-
type on an appropriate substrate: BMSSCs seeded on a bone
porcine block (BPB) in order to increase performance in
bone regeneration using scaﬀold from the block and
inducing a qualitative superior regeneration with BMSSCs.
2. Materials and Methods
2.1. Animals. Six adult minipigs of a mean age of 2 years
were used in the present study. The mean of weight was
29 kg± 4 kg. The study protocol was approved by the Italian
National Health (protocol number 7326-26/06/2013).
The animals were maintained according to the guidelines
for ethical conduct developed by the European Communities
Council Directive of November 24, 1986 (86/609/EEC). All
eﬀorts were made to minimize pain or discomfort of the
animals. In each emi-mandibula, 3 defects (5mm wide and
5mm deep) were created. The defects were then ﬁlled in
the following way: one defect with a bone porcine block
(BPB) (OsteoBiol, Tecnoss, Coazze, Italy) with BMSSCs
was inserted, one ﬁlled with bone porcine block left without
BMSSCs empty, and one defect was left blank as control. A
total of 36 critical-size circular defects (5mm diameter;
5mm thickness) were created.
2.2. In Vitro Cell Culture. Bone marrow was harvested
according to the following surgical technique.
In the minipigs, the bone marrow was harvested from the
proximal tibiae and humeri. The volume of blood circulating
in pigs is 65–75ml/kg. The animals used for the experiments
were about ~30 kg of body weight; thus, a total volume of
20ml of bone marrow per animal was safely collected, specif-
ically 5ml per bone segment considering the two humeri and
the two tibias, obtaining approximately 2×109 bone marrow
mononuclear cells (BMMNCs) per pig [25–27]. The pigs
were anesthetized as previously described. The technique
was performed in an aseptic environment and using sterile
gloves and instruments, after shaving and a thorough disin-
fection of the skin in the harvesting site. The procedure was
realized with a needle speciﬁcally built to harvest the bone
marrow, 11 gauges × 110mm, which has a cutting edge and
a spindle. The harvesting site was in correspondence with
the medial tibia and the proximal humerus of both limbs,
where the compact bone is more compliant having this area
a relatively thin cortical bone. The pigs were placed in the
lateral decubitus position. The bone marrow aspiration
needle was passed through the skin with the spindle in posi-
tion. In the the cortical bone, the spindle was removed, and
the bone marrow, in the volume of 5ml for skeletal segment,
was aspirated into a sterile syringe containing 0.2ml of
heparin (1000 units/ml). The samples were quickly trans-
ferred to the laboratory for the subsequent steps of isolation
and stem cell diﬀerentiation.
2.3. BMSSC Isolation, Culture, and Scaﬀold Preparation. In
order to obtain BMSSCs, bone marrow aspirates were proc-
essed as previously described brieﬂy [28, 29]: samples were
subjected to Histopaque 1077 density gradient (Sigma-
Aldrich, St. Louis, MO, USA). The buﬀy coat cell fraction
was entirely harvested and incubated in a humidiﬁed atmo-
sphere of 5% CO2 at 37°C to obtain the BMNCs: after 24
hours, the nonadherent cell fraction was discarded while
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the adherent cell fraction was cultured for 48–72 hours until
it reached a semiconﬂuent status (Figure 1(a)).
The BMSSC cultures, thus obtained, were trypsinized,
counted, and used to be tested and then integrated in the
scaﬀolds. To control the osteogenic diﬀerentiation, a cell frac-
tion was cultured in the presence of ascorbic acid 50ng/ml for
ten days and then stained for alkaline phosphatase (ALP)
expression as previously described (Figure 1(b)). From each
animal, 1× 106 BMSSCs were used for ﬂow cytometric assay
that demonstratedmesenchymal stem cell marker expression.
The bone porcine block scaﬀold used presented a cylindrical
shape, 5mm in diameter, and 5mm in length. They were rigid
cancellous blocks and thus are able to maintain in time the
original graft volume, which is particularly important in cases
of large regenerations.
Before being integrated with the cells, the scaﬀolds were
hydrated in alpha-MEM and incubated three times for
30min in a humidiﬁed atmosphere of 5% CO2 at 37°C. Prior
to cell seeding, the volume of medium contained in the tridi-
mensional structure of the scaﬀolds was removed by absorp-
tion using sterile cotton balls. Then 100μl BMSSC suspension
(5× 105 cells) was slowly dripped onto the scaﬀolds to avoid
overﬂow. The scaﬀolds seeded with BMSSCs were incubated
in a humidiﬁed atmosphere of 5% CO2 at 37°C for 2 h, after
which the additional culturemediumwas added to fully cover
the scaﬀolds. To ensure that cells can successfully attach to
the scaﬀolds, the cultures were incubated in a humidiﬁed
atmosphere of 5% CO2 at 37°C for 3 days. After 3 days,
50μg/ml ascorbic acid was added and the media was changed
every 2 days for two weeks in order to obtain, before scaﬀold
grafting, BMSSC osteogenic diﬀerentiation on the cells
integrated into the scaﬀolds (Figure 1(c)).
2.4. In Vivo Mandibular Defect. Surgery was performed
under general anesthesia with induction of Zoletil 100 (tileta-
mine hydrochloride + zolazepam hydrochloride) at a dosage
of 6mg/kg IM. Maintenance with isoﬂurane at 2/2.5% in
oxygen. Three bilateral critical-size circular defects (5mm
diameter; 5mm thickness) were created using a hand drill
and trephine bit in the mandibular body (Figure 2). Posterior
region of the mandible was chosen because of the presence
of regular thickness of the vestibular cortical plate; defects
were created with those speciﬁc measures to better place
the cylindrical bone porcine blocks, perfectly adapted, into
the defects. Each defect was ﬁlled randomly by the surgeon.
During the procedure, sterile saline was dripped over the
drilling site in order to avoid extensive heating and to protect
surrounding bone.
Treatment of postoperative pain with ﬂunifen (ﬂunixin
meglumine) at a dosage of 2.2mg/kg IM once (for all) or
twice depending on whether or not the animal showed
pain. Antibiotic treatment with Repen (Benzilpenicillina
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(a) (b) (c)
Figure 1: (a) In vitro appearance of BMSSCs forming a matrix nodule after two weeks of culture in the presence of osteoblast diﬀerentiation
medium. (b) Cultures of BMSSCs stained for ALP expression. (c) In vitro appearance of BMSSCs forming a matrix nodule in proximity of
BPB before grafting.
ControlBPB/BMSSCs BPB
Figure 2: Three critical-size circular defects. Clinical situation
during surgery.
ControlBPB/BMSSCs BPB
Figure 3: Standard RX 55× 75mm ﬁlms have been performed on
retrieved mandibulae to ﬁnd the perfect position and alignment of
biomaterial scaﬀolds with the bone itself.
3Stem Cells International
dihydrostreptomycin) at a dosage of 20.000 IU of Benzil-
penicillina and 12.5mg of dihydrostreptomycin/kg for 5
days IM.
2.5. Histomorphometry. The specimens were washed in saline
solution and immediately ﬁxed in 4% paraformaldehyde and
0.1% glutaraldehyde in 0.15M cacodylate buﬀer at 4°C and
pH 7.4, to be processed for histology. Cone beam computed
tomography (CBCT) (Vatech Ipax 3D PCH-6500, Fort Lee,
NJ USA) and standard RX 55× 75mm ﬁlms (Figure 3) were
performed on retrieved mandibulae. DICOM data were elab-
orated with Ez3D Plus Software (EZ3D Plus, VATECH
Global Fort Lee, NJ USA) to elaborate 3D model specimens
and ﬁnd the perfect position and alignment of biomaterial
scaﬀolds with the bone itself. CBCT analysis also permits to
evaluate interface between the scaﬀold and the surrounding
native bone. After scaﬀold position identiﬁcation by CBCT,
the posterior region of mandibulae was processed with a
band saw to obtain thin ground sections with the Precise
Automated System (Assing, Roma, Italy) The specimens were
dehydrated in an ascending series of alcohol rinses and
embedded in a glycolmethacrylate resin (Technovit 7200
VLC, Kulzer, Wehrheim, Germany). After polymerization,
the specimens were sectioned in mesiodistal direction with
50μm of distance from one slide to the subsequent one, with
a high-precision diamond disc at about 150μm and ground
down to about 30μm with a specially designed grinding
machine. A total of 3 slides were obtained for each specimen.
The slides were stained with acid fuchsin and toluidine blue,
and they were observed in normal transmitted light under a
Leitz Laborlux microscope (Leitz, Wetzlar, Germany).
Histomorphometry was carried out using a light micro-
scope (Laborlux S, Leitz, Wetzlar, Germany) connected to a
high-resolution video camera (3CCD, JVC KY-F55B, JVC®,
Santa Clara, CA, USA) and interfaced to a monitor and PC
(Intel Pentium III 1200 MMX, Intel®, Yokohama, Japan).
This optical system was associated with a digitizing pad
(Matrix Vision GmbH, Oppenweiler, Germany), and a histo-
metry software package with image capturing capabilities
(Image-Pro Plus 4.5, Media Cybernetics Inc., Immagini &
Computer Snc Milano, Italy). Evaluation of the percentages
of residual biomaterial, new bone formation, and marrow
space was performed in the mandibular defects of the three
experimental groups. Each section was examined at at least
6x magniﬁcation, and the entire area of the section was
evaluated. Digital images of each section were acquired and
used to trace the areas identiﬁed as new bone, residual parti-
cle, and marrow spaces. Image manipulation software was
used to create individual layers of new bone, residual parti-
cles, and marrow spaces. These layers were then converted
to a binary (black and white) form, and the area by percent-
age of each of the three layers was digitally calculated, based
on the number of pixels, using image analysis software.
2.6. Statistical Analysis. A power analysis was performed
using clinical software, freely available on the site http://
clincalc.com/stats/samplesize.aspx, for determining the num-
ber of bone defects needed to achieve statistical signiﬁcance
C
TB
TB
TB
TB
External portion of bone defect
Internal portion of bone defect
External portion of bone defect
Internal portion of bone defect
TB
TB
MS
MS
(a) (b)
Figure 4: (a) Control group. Trabecular bone (TB) was present in the central portion of the bone defects (c). New bone (arrows) extended to
the basal third from the margin of the bone defect. Acid fuchsin and toluidine blue. Bar = 200μ. (b) Previous image at higher magniﬁcation.
Isolated trabecular bone (TB was seen throughout the medullary space (MS). Acid fuchsin and toluidine blue. Bar = 200 μ.
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for quantitative analyses of histomorphometry. A calculation
model was adopted for dichotomous variables (yes/no eﬀect)
by putting the eﬀect incidence designed to caution the reasons
at 20% for controls and 95% for treated. The optimal number
of bone defects for analysis is 10, whereas in the present study,
12 defects were created per group.
Analysis of variance was used to determine the statistical
signiﬁcance of the diﬀerences between the three examined
groups. The percentages of new bone formation, marrow
spaces, and residual biomaterial were expressed as means ±
standard deviations. The signiﬁcance of the diﬀerences
observed was evaluated using the Bonferroni test for multi-
ple comparisons: threshold for statistical signiﬁcance was
set at P < 05.
3. Results
Histomorphometric results after analysis showed diﬀerence
in bone regeneration between the BPB and BPB/BMSSC
groups evaluated measuring percentages of the lamellar
bone, woven bone, marrow spaces, and residual BPB. The
control group showed a regular healing pattern. No macro-
scopic defects were found after three months.
3.1. Controls. Bone tissue was evident with well-diﬀerentiated
cells and mineralized matrix: osteoid, osteoblasts, osteocytes,
and blood vessels. Regenerating osseous tissue extending
from the margin of the axial walls was observed. Fibrous
tissue still occupied little space in the defect area (Figure 4).
Traces of new bone from the periosteum were observed,
overlying the superﬁcial portion of the bone defect. The tis-
sues present in the defect were composed of 23± 2% of the
lamellar bone, 28± 1% of the woven bone, and 56± 4% of
the marrow spaces.
3.2. Bone Porcine Block (BPB). At low magniﬁcation, it was
possible to observe that almost all the block materials were
surrounded by the mature bone: only around some ﬁelds
was it possible to observe the presence of the osteoid material.
The material particles were near marrow spaces in only a few
areas. In all specimens, no acute inﬂammatory cell inﬁltrate
or foreign body reactions were present around the particles
or at the interface with the bone. All blocks were colonized
and surrounded by the newly formed bone (Figure 5(a)).
This bone was woven or lamellar. Inside the BPB, there was
always the presence of newly formed bone. No epithelial cells
or connective tissues were observed at the interface. The
regenerated bone tissue extended to approximately all of
the bone defects except in the central area, where the ﬁbrous
tissue still occupied a part of the interparticular spaces.
Prominent lamination of the mature bone was observed.
The periphery and central portion of the experimental cavi-
ties showed mineralized new bone formation (Figure 6(a)).
The bone defects were not completely healed, and many par-
ticles or BPB were visible. The tissues present in the defects
were composed of 20± 5% of BPB, by 32± 2% of the lamellar
External portion of bone defect
Internal portion of bone defect
BPB
BPB BPB BPB
External portion of bone defect
Internal portion of bone defect
BPBBPB
BPB
(a) (b)
Figure 5: (a) BPB group. New bone surrounded the block material (BPB). New bone (arrows) extended also in the central part of the bone
defects. Acid fuchsin and toluidine. Bar = 200 μ. (b) BPB/BMSSCs group. New bone (arrows) was deposited in the block material (BPB). No
ﬁbrous tissue was observed in the defect area. Acid fuchsin and toluidine. Bar = 200 μ.
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bone, 24± 1% of the woven bone, and by 28± 2% of the
marrow spaces.
3.3. Bone Porcine Block with Bone Marrow Stromal Stem Cells
(BPB/BMSSCs). Regenerating osseous tissue was observed
surrounding someBPB extending from themargin of the axial
walls. Bone tissue was deposited in the block (Figure 5(b)).
New bone extended to the basal third from the margin of
the bone defect and partially surrounded the BPB block.
New bone extended also in the central part of the bone
defects (Figure 5(b)). No ﬁbrous tissue was observed in the
defect area. Traces of new bone from the periosteum were
seen overlying the superﬁcial portion of the bone defect.
Bone morphology was more mature and well organized pre-
senting a lamellar pattern compared with bone around
defect. Higher magniﬁcation of the bone tissue around the
block showed that no gaps were present at the bone-
biomaterial interface, and the bone seemed to always be in
close contact with the block (Figure 6(b)). In some ﬁelds,
osteoblasts were observed in the process of apposing bone
directly on the block surface. No acute inﬂammatory cells
inﬁltrate, or foreign body reactions were present around
the particles or at the interface with the bone. All defects
were ﬁlled with newly formed dense bone and bone marrow.
The tissues present in the defects were composed of 17± 4%
of BPB/BMSSCs, by 42± 2% of the lamellar bone, 12± 1% of
the woven bone, and by 22± 3% of the marrow spaces.
3.4. Statistical Evaluation. Statistically signiﬁcant diﬀerences
were found in the percentage of the marrow space and lamel-
lar bone between the three groups (P < 001). In detail,
between BPB and BMSSCs/BPB, the diﬀerence of the lamel-
lar and woven bones was found to be statistically signiﬁcant
with P < 001 and P < 01 considering marrow spaces, while
no diﬀerence was found in biomaterial percentage between
the two test groups (Figure 7).
4. Discussion
This study found a relevant diﬀerence in bone regeneration
using a bone porcine block scaﬀold seeded with bone marrow
stromal stem cells when compared with bone porcine block
without any kind of treatment. Literature presents a variety
of enriching stem/progenitor cells for use in cell-based bone
regeneration. They have been explored both clinically and
experimentally with varying degrees of success. Bone porcine
block scaﬀolds are promising for a variety of tissue engineer-
ing applications. BPB scaﬀolds have a hard structure which
prevents defects and creates the correct environment for
bone regeneration without the risk of soft tissue colonization.
BPB scaﬀolds are perfect material for local bone regeneration
due to their biocompatibility, osteoconductivity [30], and
porosity which allows for eﬃcient BMSSC seeding and
growth [31]. BPB biodegradation analysis was not the aim of
this study, so the relationship between scaﬀold biodegradation
BPB
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Osteon
V
V
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(a) (b)
Figure 6: (a) BPB group. Bone tissue was deposited in the block material (BPB). No ﬁbrous tissue was observed in the defect area. Vessels (V)
were present in the central part of the bone defects. New bone (NB) and osteoblasts in close contact with the block material acid fuchsin and
toluidine blue. Bar = 100 μ. (b) BPB/BMSSCs group. Mature bone (MB) in the bone defect. Bone morphology was more mature and well
organized, presenting a primary osteon. A basic multicellular unit of osteoclasts cells (yellow arrows) that dissolves an area of the bone
surface and then ﬁlls it with new bone by osteoblasts (white arrows) to form haversian systems or osteons. A vessels (V) were present in
the central part of the bone defects. Acid fuchsin and toluidine blue. Bar = 100μ.
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and bone formation has not been studied in detail, only
measured as a percentage in histological evaluations.
In the present study, a 3D software analysis of CBCT was
performed and histological images were acquired in which
BPB implants were well positioned and induced a higher
amount of BMD and SUV within the mandibular defects as
compared to BPB without BMSSCs. Despite the contribution
of BMSSCs, bone formation is visible in both groups. This
study aimed to further characterize bone regeneration
induced by BMSSCs in these scaﬀold-based implants by
using histological parameters. The percentages of residual
biomaterial, new bone formation, and marrow spaces in the
mandibular defects ﬁlled with BPB alone or in combination
with BMSSCs were evaluated. Histomorphometry was car-
ried out individually for bone, marrow spaces, and residual
graft material with a measure error, and the sum will never
give 100. Moreover, a qualitative description of the histomor-
phology of the mandibular defects was provided. The
description included the characterization of newly formed
bone, the presence of inﬂammatory cell inﬁltrate, and the
position of bone formation within the defects. The histomor-
phometric results showed that, at the observed time, the
amount of marrow spaces and residual graft material more
than new bone formation are always quite diﬀerent from
100%, this is due to the fact that the three measurements
are carried out individually with a margin of error and then
the sum of the error is inclusive of the measurement
performed in the BPB, lamellar bone, or woven bone and
marrow spaces. The results showed that although the
percentage of residual biomaterial was similar among the
experimental groups, the percentage of formation of new
bone and marrow space was diﬀerent. The present study
showed that the BPB/BMSSC group resulted in a signiﬁcantly
greater bone formation in alveolar bone defects in the mini-
pig mandible than BPB groups alone. This suggests that
BPB can produce synergic eﬀect with BMSSCs. The minipig
was chosen as an animal model because of its similarities to
humans in terms of platelet count, clotting parameters,
metabolic rate, bone structure, and characteristics of their
MSCs [32]. An alveolar defect model oﬀers several advan-
tages for the histologic evaluation of bone tissue-engineered
constructs. The surgical procedure is simple, with a limited
risk of infection, and a similar intervention by grafting is
advocated clinically. A true critical-sized mandibular defect
in the minipig model is more than 5mm [33]. Recently, the
synergic eﬀect of MSCs and platelet-rich plasma incorpo-
rated into a scaﬀold on ﬂuorohydroxyapatite and bone
formation in surgical bone defects in the edentulous mandi-
ble of minipigs has been reported [34]. These results suggest
that MSCs show a positive eﬀect on bone formation when
combined with autologous growth factors [34]. In fact, the
platelet growth factors and biomaterial combination were
used with success for bone regeneration [35] and soft tissue
augmentation [36, 37]. In the present study, a mandibular
defect model was chosen to determine the potential ability
of BPB to enhance bone formation when it was supple-
mented by BMSSCs. Each minipig served as its own control.
In our study, BPB alone was used as a scaﬀold material for
testing BMSSC bone induction. The reason for selecting this
particular biomaterial was that BPB has been proven to be a
suitable carrier for osteoblast-like cells, bone morphogenic
proteins, and growth factors. This particular biomaterial
has been proven to be a suitable carrier for osteoblast in ver-
tical ridge augmentation of atrophic posterior mandible [38].
This biomaterial has a hard consistency and can be used to
block the fragments of the osteotomized segments. When
BPB was placed in the surgically created defects, it became
properly integrated in the newly lamellar bone during healing
[39]. This indicates that the material was osteoconductive
and acted as a natural scaﬀold for new bone formation.
Biocompatibility of BPB was conﬁrmed by histological
analysis [40]. The formation of a ﬁbrous capsule around the
particles did not occur in any section. In this respect, the
current ﬁndings are consistent with observations made in
human histologic studies. These studies indicate that an inti-
mate contact is always established between BPB particles and
newly formed mineralized bone [40]. The present ﬁndings
show that the superior contribution of BMSSCs to bone
regeneration is due to the formation of mature (lamellar)
bone. Moreover, the contribution of stem cells is evident
when analyzing the percentage of woven bone. Qualitative
histomorphometry also showed that seeding of stem cells
into the scaﬀolds resulted in greater bone formation in
BPB/BMSSCs construct. This is evidenced by the presence
of bone tissue in the periphery and in the central area of
the defect. Most notably, osteogenesis was observed in the
absence of inﬂammatory processes which may interfere with
the process of regeneration [41].
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bone marrow stromal stem cells/bone porcine block.
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5. Conclusion
This study demonstrates that BPB when used as a scaﬀold to
induce bone regeneration may beneﬁt from the addition of
BMSSCs in the tissue-engineered constructs. Our data shows
the healing pattern in a minipig model, but further research is
needed for human applications.
Abbreviations
BMMNC: Bone marrow mononuclear cell
BMSSC: Bone marrow stromal stem cell
BPB: Bone porcine block.
Additional Points
Research Highlights. Bone marrow stromal stem cells
(BMSSCs) were obtained from 6 minipigs. BMSSCs are suit-
able to be seeded and cultured on a biomaterial such as bone
porcine block (BPB). BMSSCs on BPB showed better results
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